Immunomodulation of atherosclerosis: implications for vaccine development.
A number of studies have shown activation of the immune system throughout various stages of atherosclerosis. Recent observations have suggested that activation of immune responses may promote atherosclerosis on one hand by inducing and perpetuating arterial inflammation, whereas on the other hand, selective activation of certain immune functions may inhibit atherosclerosis and arterial inflammation. These observations suggest the possibility that selective suppression of proatherogenic immune responses or selective activation of antiatherogenic immune responses may provide new approaches for atherosclerosis prevention and treatment. Several antigens activating immune responses affecting development of atherosclerosis have been identified. These immune responses may be modulated by presenting the antigens together with different types of adjuvants as well as through the route of administration. In this review, we summarize recent experimental studies using immunomodulatory approaches for treatment of atherosclerosis.
Nilsson
Jan
J
Department of Medicine, Malmö University Hospital, Lund University, Sweden. Jan.Nilsson@medforsk.mas.lu.se
Hansson
Göran K
GK
Shah
Prediman K
PK
D000818:Animals; D000941:Antigens / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000517:prevention & control*; D006801:Humans; D007108:Immune Tolerance; D014612:Vaccines / Q000627:therapeutic use*
D000941:Antigens; D014612:Vaccines